financetom
NFLX
financetom
/
Communication Services
/
NFLX
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Netflix, Inc.NFLX
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and mobile games across various genres and languages.

The company provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, television set-top boxes, and mobile devices.

The company has approximately 231 million paid members in 190 countries. Netflix, Inc. was incorporated in 1997 and is headquartered in Los Gatos, California.

Latest News >
BP Confirms Discovery in Namibia's Orange Basin
BP Confirms Discovery in Namibia's Orange Basin
Oct 20, 2025
10:02 AM EDT, 10/20/2025 (MT Newswires) -- BP (BP) confirmed Monday the gas condensate discovery reported by Rhino Resources in Namibia's Orange Basin. The Volans-1X exploration well encountered 26 meters of net pay in rich gas condensate-bearing reservoirs, BP said, adding that the reservoir showed excellent petrophysical properties and no observed water contact. The well is drilled under Petroleum Exploration...
Form 8.3 - NCC group plc
Form 8.3 - NCC group plc
Oct 20, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: First Trust Advisors L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Palisade Bio Says First Patients Dosed in Phase 1b Trial of PALI-2108 to Treat Fibrostenotic Crohn's Disease
Palisade Bio Says First Patients Dosed in Phase 1b Trial of PALI-2108 to Treat Fibrostenotic Crohn's Disease
Oct 20, 2025
10:05 AM EDT, 10/20/2025 (MT Newswires) -- Palisade Bio ( PALI ) said Monday the first patients have been dosed in a phase 1b trial assessing PALI-2108 to treat fibrostenotic Crohn's disease. Topline results are expected in Q1 2026, the company said. The phase 1b trial will enroll about 6 to 12 patients with the disease, the company said, adding...
Snowflake Unusual Options Activity
Snowflake Unusual Options Activity
Oct 20, 2025
Investors with a lot of money to spend have taken a bullish stance on Snowflake . And retail traders should know. We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SNOW,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved